(Q34604800)

3 August 2017

1 reference

title

Natural products and chronic hepatitis C virus (English)

1 reference

3 August 2017

1 reference

1 reference

1 reference

1 reference

1 reference

Azzam HS

1

1 reference

3 August 2017

Goertz C

series ordinal

2

1 reference

3 August 2017

Fritts M

series ordinal

3

1 reference

3 August 2017

Jonas WB

series ordinal

4

1 reference

3 August 2017

publication date

1 February 2007

1 reference

3 August 2017

1 reference

3 August 2017

volume

27

1 reference

3 August 2017

issue

1

1 reference

3 August 2017

page(s)

17-25

1 reference

Pathogenesis, natural history, treatment, and prevention of hepatitis C.

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2006.01408.X

Screening for hepatitis C virus infection: a review of the evidence for the U.S. Preventive Services Task Force

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2006.01408.X

Toxicological aspects of Kampo medicines in clinical use

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2006.01408.X

Lactoferrin inhibits hepatitis B virus infection in cultured human hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2006.01408.X

Dose-response trial of lactoferrin in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2006.01408.X

Radix Sophorae flavescentis for chronic hepatitis B: a systematic review of randomized trials

21 January 2018

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.1142/S0192415X03001107

Identifiers

DOI

10.1111/J.1478-3231.2006.01408.X

1 reference

3 August 2017

1 reference